Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanofi Eyes Chattem As Key Building Block For Global OTC Growth

This article was originally published in The Tan Sheet

Executive Summary

Sanofi-Aventis' $1.9 billion bid for OTC and personal care product firm Chattem offers the French firm a coveted toehold in the sizeable U.S. consumer health care market while also opening potential opportunities in emerging markets

Related Content

Prestige Brands Makes "Seismic Shift" To OTC With Blacksmith Acquisition
Meda Lands In U.S. OTC Space With Alaven Buy
Sales & Earnings In Brief
Carlyle Group's $3.8B Bid For NBTY Could Face Competition
Blacksmith Brands Aims To Forge A Platform From Undervalued OTC Products
Sanofi completes Chattem deal
Sanofi-Aventis acquires marketing rights to Xyzal
Sales & Earnings In Brief
Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions
Pharma Firms Stir OTC Market, FDA Hones Enforcement: Top Stories Of 2009





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts